Zynex, Inc. (ZYXI)

Market Cap	346.43M
Revenue (ttm)	142.99M
Net Income (ttm)	19.72M
Shares Out	38.41M
EPS (ttm)	0.49
PE Ratio	18.41
Forward PE	15.82
Dividend	$0.10 (1.11%)
Ex-Dividend Date	n/a

Volume	152,868
Open	8.72
Previous Close	8.66
Day's Range	8.72 - 9.22
52-Week Range	4.97 - 14.24
Beta	0.81
Analysts	Buy
Price Target	16.96 (+88.0%)
Earnings Date	Oct 31, 2022

About ZYXI

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InW...

• Industry: Health Care Equipment & Supplies
• Founded: 1996
• Employees: 774
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYXI

Full Company Profile

Financial Performance

In 2021, Zynex's revenue was $130.30 million, an increase of 62.63% compared to the previous year's $80.12 million. Earnings were $17.10 million, an increase of 88.48%.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for ZYXI stock is "Buy." The 12-month stock price forecast is 16.96, which is an increase of 88.03% from the latest price.

Price Target

$16.96

(88.03% upside)

Analyst Consensus: Buy

Stock Forecasts